KLRA compared with WAY: revenue, margins and what each company keeps, and the suppliers and customers both name

KLRAKailera Therapeutics, Inc.

Mkt capRevenueRevenue

WAYWaystar Holding Corp.

Mkt capRevenueRevenue

Compare

KLRAKailera Therapeutics, Inc.

WAYWaystar Holding Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only KLRA 1

—Hengruiunlistedsupplier

Shared 0

No shared counterparties.

Only WAY 2

PNCPNC Bank, National Associationsupplier

—PNC Capital Marketsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

KLRAKailera Therapeutics, Inc.

12.62▲+3.84%

Mkt cap$1.3BRevenue—Revenue—

WAYWaystar Holding Corp.

26.57▼−5.56%

Regular sessionNov 3 '26

Mkt cap$5.4BRevenue$326MQ3 FY26Revenue$1.1BFY25

Compare

Regular sessionNov 3 '26

KLRAKailera Therapeutics, Inc.

WAYWaystar Holding Corp.

12.62▲+3.84%

Price

26.57▼−5.56%

$1.3B

Mkt cap

$5.4B

—

Revenue

$326MQ3 FY26

—

Revenue

$1.1BFY25

KLRA12.62▲+3.84%vsWAY26.57▼−5.56%Regular sessionNov 3 '26